You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Central Nervous System Neoplasm

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
Has Results
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in BRAF Mutated

Recruiting
  • Metastatic Melanoma
    • Montpellier, France
      Uhmontpellier
    Aug 19, 2022

    Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Saint Louis (Durvalumab, Acalabrutinib)

    Recruiting
    • Primary Central Nervous System Lymphoma
    • Secondary Central Nervous System Lymphoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 14, 2022

    5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for

    Not yet recruiting
    • High Grade Glioma
    • +10 more
    • 5-Aminolevulinic Acid (5-ALA) Gliolan®
    • Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 28, 2023

    Specimen Banking for People With Tumors of Central Nervous

    Recruiting
    • Brain Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 7, 2022

      Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

      Not yet recruiting
      • Breast Carcinoma
      • +2 more
      • Biospecimen Collection
      • +6 more
      • Chicago, Illinois
        Northwestern University
      Nov 14, 2023

      Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

      Recruiting
      • Secondary Central Nervous System Lymphoma
      • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      May 25, 2022

      Malignant CNS Tumor, Metastatic Malignant Tumor in the CNS Trial in Palo Alto (other, drug, procedure)

      Suspended
      • Malignant Central Nervous System Neoplasm
      • Metastatic Malignant Neoplasm in the Central Nervous System
      • Gadolinium
      • +3 more
      • Palo Alto, California
        Stanford University School of Medicine
      Aug 2, 2021

      Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)

      Terminated
      Has Results
      • Malignant Melanoma
      • Brain Metastases
      • Tucson, Arizona
        University of Arizona Cancer Center
      Mar 5, 2022

      CNS Tumor, Glioma, Metastatic Malignant Tumor in the CNS Trial in Houston (7 Tesla Magnetic Resonance Imaging, Questionnaire

      Unknown status
      • Central Nervous System Neoplasm
      • +3 more
      • 7 Tesla Magnetic Resonance Imaging
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 3, 2021

      Metastatic Cancer, CNS Cancer Trial in Boston (Niraparib)

      Recruiting
      • Metastatic Cancer
      • Central Nervous System Cancer
      • Boston, Massachusetts
      • +2 more
      Jan 28, 2022

      Breast Carcinoma, Carcinoma of Unknown Primary, CNS Carcinoma Trial in Scottsdale, Jacksonville (Biospecimen Collection, Genetic

      Recruiting
      • Breast Carcinoma
      • +10 more
      • Biospecimen Collection
      • Genetic Testing
      • Scottsdale, Arizona
      • +1 more
      Jul 15, 2022

      Retinoblastoma, Extraocular Trial in Shanghai (Melphalan)

      Recruiting
      • Retinoblastoma, Extraocular
      • Shanghai, China
        Fudan Eye & ENT Hospital
      Aug 26, 2021

      Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

      Recruiting
      • Brain and Central Nervous System Tumors
      • +8 more
      • 3'-deoxy-3'-[18F]fluorothymidine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Mar 30, 2022

      HER2-positive Metastatic Breast Cancer, CNS Metastases Trial in Chicago, Boston (ATEZOLIZUMAB, PERTUZUMAB, TRASTUZUMAB)

      Active, not recruiting
      • HER2-positive Metastatic Breast Cancer
      • Central Nervous System Metastases
      • Chicago, Illinois
      • +1 more
      Mar 14, 2022

      Malignant Tumors of Eye Brain and Other Parts of CNS Trial in Houston (Spine Radiosurgery, Questionnaires)

      Recruiting
      • Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
      • Spine Radiosurgery
      • Questionnaires
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 22, 2022

      Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

      Withdrawn
      • Breast Cancer
      • +3 more
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jun 28, 2022

      Tumor Metastasis, CNS Metastases Trial in Albuquerque (Intensity Modulated Radiotherapy)

      Completed
      • Neoplasm Metastasis
      • Central Nervous System Metastases
      • Intensity Modulated Radiotherapy
      • Albuquerque, New Mexico
        Universtiy of New Mexico Comprehensive Cancer Center
      Apr 21, 2022

      Collecting and Storing Blood Samples From Patients With Cancer

      Withdrawn
      • Brain and Central Nervous System Tumors
      • +10 more
        • (no location specified)
        Sep 20, 2021

        Brain Metastases, CNS Tumor, CNS Disorder, Intracranial Trial in Australia, United States (Stereotactic radiosurgery)

        Recruiting
        • Brain Metastases
        • +2 more
        • Stereotactic radiosurgery
        • Birmingham, Alabama
        • +4 more
        Jul 13, 2022

        Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker

        Completed
        • Childhood Solid Neoplasm
        • +4 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Birmingham, Alabama
        • +20 more
        Apr 12, 2021

        Acute and Late Normal Tissue in Patients Treated With Proton

        Recruiting
        • Breast Carcinoma
        • +8 more
        • Quality-of-Life Assessment
        • Questionnaire Administration
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 11, 2020

        Patterns and Clinical Outcomes in Central Nervous System

        Completed
        • Central Nervous System Tuberculosis
          • Wuhan, Hubei, China
          • +1 more
          Aug 25, 2023

          Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

          Completed
          • Brain and Central Nervous System Tumors
          • +10 more
          • Chicago, Illinois
            Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
          Sep 3, 2021

          Somatic Mosaicism in Twins Discordant for Childhood Cancer

          Not yet recruiting
          • Pediatric Central Nervous System Tumor
          • +3 more
          • Biospecimen collection
          • Questionnaire Administration
          • (no location specified)
          Sep 19, 2023